• Client Login
Ozmosi
  • Services
    • BEAM Clinical Trial Data
    • GCT Global Clinical Trials
    • PRYZM Pharma Product Database
    • KRYSTL Industry Scan Reporting
    • LENZ Company Pipeline Summary
    • Specialized Consulting
    • Approved Pharmaceutical Products in Use
  • About Us
  • Case Studies
  • Newsroom
  • Conference Info
  • Contact Us
Select Page

A Gift for Patients – Medicare to Cover Lung Cancer Screening

Oct 27, 2018 | Cancer, Industry Trends

LUNG CANCER SCREENING UPDATE: As of February 5, 2015, effective immediately, Medicare will cover lung cancer screening by low-dose CT. The Centers for Medicare & Medicaid Services (CMS) recently issued a proposal for Medicare to cover the cost of lung cancer...

Recent Posts

  • OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&DMay 13, 2026
  • Pharmaceutical Portfolio Strategy in the AI Era: Why External Intelligence MattersApril 29, 2026
  • Why AI Stalls in Pharmaceutical R&D Operations (and How to Fix It)March 31, 2026
  • Who is Winning in Innovation and How are They Balancing Risk?February 28, 2026
  • How Next-Generation Probability of Success Forecasting Can Improve Clinical Trial Accuracy by 44%January 16, 2026
  • Market Overview: GLP-1 Agonists and the Obesity MarketDecember 16, 2025
  • Home
  • About Us
  • Services
  • Case Studies
  • Newsroom
  • Contact Us
  • Facebook
  • X
OZMOSI© 2025 | All Rights Reserved | Site by Webtyde